Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Barone

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
The Lancet. Oncology|June 1, 2026
Aglatimagene besadenovec (CAN-2409) with radiotherapy for patients with localised prostate cancer: a phase 3, multicentre, randomised, double-blind, placebo-controlled trialTheodore L DeWeese, Andrea Manzanera, John Sylvester, et al.
Nature|December 13, 2025
Author Correction: Distinct fibroblast subsets drive inflammation and damage in arthritisAdam P Croft, Joana Campos, Kathrin Jansen, et al.
Nature|May 31, 2019
Distinct fibroblast subsets drive inflammation and damage in arthritisAdam P Croft, Joana Campos, Kathrin Jansen, et al.
Annals of the Rheumatic Diseases|September 23, 2020
Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjögren's syndrome with ectopic germinal centres and MALT lymphomaElena Pontarini, William James Murray-Brown, Cristina Croia, et al.
Nature Medicine|April 21, 2015
Homeostatic regulation of T cell trafficking by a B cell-derived peptide is impaired in autoimmune and chronic inflammatory diseaseMyriam Chimen, Helen M McGettrick, Bonita Apta, et al.
Swiss Medical Weekly|February 15, 2018
Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: examination of data from the UK Primary Sjögren's Syndrome RegistryAlexandre Dumusc, Wan-Fai Ng, Katherine James, et al.
Nature Immunology|July 7, 2015
Inflammation-induced formation of fat-associated lymphoid clustersCécile Bénézech, Nguyet-Thin Luu, Jennifer A Walker, et al.
The Lancet. Rheumatology|January 24, 2024
Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept studyBenjamin A Fisher, Antonia Szanto, Wan-Fai Ng, et al.
Rheumatology (Oxford, England)|October 3, 2017
Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome RegistryClare Oni, Sheryl Mitchell, Katherine James, et al.
Rheumatology (Oxford, England)|October 30, 2015
Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome RegistryClare Oni, Sheryl Mitchell, Katherine James, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
The Lancet. Oncology|June 1, 2026
Aglatimagene besadenovec (CAN-2409) with radiotherapy for patients with localised prostate cancer: a phase 3, multicentre, randomised, double-blind, placebo-controlled trialTheodore L DeWeese, Andrea Manzanera, John Sylvester, et al.
Nature|December 13, 2025
Author Correction: Distinct fibroblast subsets drive inflammation and damage in arthritisAdam P Croft, Joana Campos, Kathrin Jansen, et al.
Nature|May 31, 2019
Distinct fibroblast subsets drive inflammation and damage in arthritisAdam P Croft, Joana Campos, Kathrin Jansen, et al.
Annals of the Rheumatic Diseases|September 23, 2020
Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjögren's syndrome with ectopic germinal centres and MALT lymphomaElena Pontarini, William James Murray-Brown, Cristina Croia, et al.
Nature Medicine|April 21, 2015
Homeostatic regulation of T cell trafficking by a B cell-derived peptide is impaired in autoimmune and chronic inflammatory diseaseMyriam Chimen, Helen M McGettrick, Bonita Apta, et al.
Swiss Medical Weekly|February 15, 2018
Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: examination of data from the UK Primary Sjögren's Syndrome RegistryAlexandre Dumusc, Wan-Fai Ng, Katherine James, et al.
Nature Immunology|July 7, 2015
Inflammation-induced formation of fat-associated lymphoid clustersCécile Bénézech, Nguyet-Thin Luu, Jennifer A Walker, et al.
The Lancet. Rheumatology|January 24, 2024
Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept studyBenjamin A Fisher, Antonia Szanto, Wan-Fai Ng, et al.
Rheumatology (Oxford, England)|October 3, 2017
Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome RegistryClare Oni, Sheryl Mitchell, Katherine James, et al.
Rheumatology (Oxford, England)|October 30, 2015
Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome RegistryClare Oni, Sheryl Mitchell, Katherine James, et al.
Pageof 14